Home › Mesothelioma › Colorado
Pag-aaral pangklinika para sa Mesothelioma sa Colorado
8 pag-aaral para sa Mesothelioma ang naghahanap ng mga kalahok sa mga site sa Colorado.
Mga Lungsod sa Colorado
Opisyal na teksto ng pag-aaral (English)
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- SCRI at HCA HealthONE, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- Sarah Cannon Research Institute at HealthONE, Denver
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06566079Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Grand Valley Oncology, Grand Junction
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05245500Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06756035A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- University of Colorado Cancer Center, Aurora
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06362369A Study of NX-1607 in Adults With Advanced Malignancies
- University of Colorado School of Medicine, Aurora
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.